Kevin Joseph Fitzgerald - Dec 12, 2024 Form 4 Insider Report for Ovid Therapeutics Inc. (OVID)

Role
Director
Signature
/s/ Chris Matteodo, Attorney-in-Fact
Stock symbol
OVID
Transactions as of
Dec 12, 2024
Transactions value $
$0
Form type
4
Date filed
12/16/2024, 04:15 PM
Previous filing
Nov 27, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OVID Stock Option (Right to Buy) Award $0 +90K $0.00 90K Dec 12, 2024 Common Stock 90K $1.06 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares will vest in 36 equal monthly installments, subject to the Reporting Person's continued services through such date.